Financial Outlook
Fiscal year 2023 (July 2022-June 2023) was a year of investment for ASH. ASH continued its mission to foster high-quality equitable care, transformative research, and innovative education to improve the lives of patients worldwide with blood and bone marrow disorders.
Explore the 2023 Annual Report
